Blog

Read more

This presentation covers: net.Zero manufacturing in combination and support of MES Global standardization program How to develop a business case for MES and net.Zero manufacturing Which infrastructure is needed for each customer How to continuously improve your processes after implementationRead more

Read more

Get coffee, get snacks, make connections and talk with your peers – and have the chance to actively participate in product and service demos on the expo floor.  Read more

Identify requirements and suggestions from pharmaceutic production experts to enable a smooth rollout of a Pharma MES systems What risks are seen and how to avoid them? Focus areas and functional priorities for the initial Pharma MES rollout phase in a step by step rollout scenario How to organize a Pharma MES rollout and achieveRead more

The concept of EBR has been in place for decades, but Tier 2 sites have often struggled to implement them due to the high costs and technical complexities involved. We will focus on the challenges these facilities face in terms of modernising their infrastructure, processes and systems to keep up with the rapid evolving technology of the pharma industry. However,Read more

Apotex is putting multiple sites in one global MES paperless EBR system to create fast workflows, loose paper recipes completely and discuss best practice validation approaches and its requirements. The goal is to achieve one global template followed by an agile MES rollout on all sites and to find a way in doing so thatRead more

This presentation covers: Discover how AI and Mixed Reality interact using Microsofts low-code PowerPlatform in a regulated environment Redesigning the future business processes with AI and real-time holographic assistance Learn how Mixed Reality is making an impact with NNITs key Life Sciences customers through existing use cases.Read more

Get coffee, get snacks, make connections and talk with your peers – and have the chance to actively participate in product and service demos on the expo floor.    Read more

What do the shift to new modalities, the specialization of manufacturing methods, and pharma companies’ revenue shift from a blockbuster drug to a portfolio have in common? All three have led to a more decentralized pharmaceutical supply chain. Learn how to build a connected manufacturing network to: Achieve enterprise-level visibility across internal and external capacityRead more